Safety and efficacy of anti–tumor necrosis factor α therapy in ten patients with recent‐onset refractory reactive arthritisAlain Meyer, Emmanuel Chatelus, Daniel Wendling et al.|Arthritis & Rheumatism|2011Cited by 81